Savant Capital LLC Sells 1,273 Shares of Ingevity Co. (NYSE:NGVT)

Savant Capital LLC lowered its stake in Ingevity Co. (NYSE:NGVT) by 1.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 84,993 shares of the company’s stock after selling 1,273 shares during the period. Savant Capital LLC owned approximately 0.23% of Ingevity worth $3,463,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently modified their holdings of NGVT. AQR Capital Management LLC bought a new position in shares of Ingevity in the second quarter worth $367,000. Inspire Investing LLC grew its position in Ingevity by 30.5% in the third quarter. Inspire Investing LLC now owns 10,454 shares of the company’s stock valued at $408,000 after acquiring an additional 2,441 shares during the last quarter. nVerses Capital LLC bought a new position in Ingevity in the third quarter valued at about $113,000. Blue Trust Inc. grew its position in Ingevity by 179.6% in the third quarter. Blue Trust Inc. now owns 2,505 shares of the company’s stock valued at $98,000 after acquiring an additional 1,609 shares during the last quarter. Finally, Everence Capital Management Inc. grew its position in Ingevity by 47.8% in the third quarter. Everence Capital Management Inc. now owns 6,090 shares of the company’s stock valued at $238,000 after acquiring an additional 1,970 shares during the last quarter. Institutional investors own 91.59% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, BMO Capital Markets lifted their target price on Ingevity from $40.00 to $47.00 and gave the company a “market perform” rating in a research report on Thursday, October 31st. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $52.17.

Ingevity Stock Performance

Shares of NGVT stock opened at $45.44 on Wednesday. The business’s 50-day moving average price is $43.53 and its 200-day moving average price is $40.90. Ingevity Co. has a 12 month low of $30.90 and a 12 month high of $56.29. The firm has a market capitalization of $1.65 billion, a price-to-earnings ratio of -2.93 and a beta of 1.64. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 6.52.

Ingevity Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.